Medicare Enrolled
Dr. Marc Feder, M.D.
Urology Physician · East Brunswick, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Feder from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Feder?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Feder
Dr. Marc Feder is an urology physician in East Brunswick, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Feder performed 4,029 Medicare services across 2,867 unique beneficiaries.
Between the years covered by Open Payments, Dr. Feder received a total of $5,398 from 17 pharmaceutical and/or device companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Feder is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 39% volume in NJ
$5,398 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,029
Medicare services
Top 39% in NJ for urology physician
2,867
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~252 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
871 | $104 | $274 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
423 | $74 | $188 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
361 | $8 | $15 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
323 | $42 | $168 |
| PSA test (prostate cancer screening) | 288 | $18 | $76 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
271 | $2 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 156 | $136 | $488 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
129 | $8 | $35 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
125 | $8 | $33 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
125 | $8 | $34 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
112 | $125 | $412 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
105 | $213 | $890 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
68 | $48 | $116 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
65 | $86 | $274 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
64 | $8 | $13 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
62 | $8 | $33 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
61 | $120 | $336 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
53 | $107 | $336 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $63 | $179 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
48 | $28 | $121 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
47 | $50 | $201 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
46 | $56 | $425 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
43 | $68 | $350 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
25 | $109 | $1,443 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
24 | $21 | $59 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
22 | $92 | $370 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
17 | $589 | $11,395 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
16 | $67 | $181 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
15 | $106 | $2,500 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $366 | $2,290 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
13.7% medium
85.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,398
Total received (2018-2024)
Avg $771/year across 7 years
Top 22% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
63
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,437 (82.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$757 (14.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$204 (3.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$962
2023
$46
2022
$105
2021
$3,654
2020
$176
2019
$222
2018
$233
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Clarius Mobile Health Corp.
$962
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Clarius Mobile Health Corp.
$4,437
Astellas Pharma US Inc
$200
Dendreon Pharmaceuticals LLC
$164
PFIZER INC.
$140
Janssen Biotech, Inc.
$81
Boston Scientific Corporation
$69
Ambu Inc.
$61
AstraZeneca Pharmaceuticals LP
$56
Bayer HealthCare Pharmaceuticals Inc.
$55
TOLMAR Pharmaceuticals, Inc.
$28
C. R. Bard, Inc. & Subsidiaries
$20
UROGEN PHARMA, INC.
$18
UroGen Pharma, Inc.
$16
Olympus America Inc.
$15
Janssen Scientific Affairs, LLC
$14
Allergan Inc.
$13
Medtronic USA, Inc.
$12
Top 3 companies account for 88.9% of all-time payments
Associated products mentioned in payments ›
BOTOX · ELIGARD · ERLEADA · Erleada · GENERAL KIDNEY STONE DISEASE · GREENLIGHT · INTERSTIM · JELMYTO · LYNPARZA · MYRBETRIQ · Nubeqa · PROVENGE · REZUM · TOVIAZ · XTANDI · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (82%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Urology physicians within 10 mi
180
Per 100K population
20.9
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Feder is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Feder experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Feder performed 871 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Feder receive payments from pharmaceutical companies?
Yes. Dr. Feder received a total of $5,398 from 17 companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Feder's costs compare to other urology physicians in East Brunswick?
Dr. Feder's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Feder) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in East Brunswick
Browse urology physicians in East Brunswick ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Clarius Mobile Health Corp. Payments to Doctors
See all physicians who received payments from Clarius Mobile Health Corp.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology